GENPHARMASEC
Back to Balance Sheet
|
GENPHARMASEC Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2.70 Cr | ₹2.06 Cr | ₹6.28 Cr | ₹7.16 Cr | ₹5.72 Cr |
What is the latest Total Current Liabilities ratio of GENPHARMASEC ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2.70 Cr |
Mar2023 | ₹2.06 Cr |
Mar2022 | ₹6.28 Cr |
Mar2021 | ₹7.16 Cr |
Mar2020 | ₹5.72 Cr |
How is Total Current Liabilities of GENPHARMASEC Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2.70 Cr | 30.67 | |
Mar2023 | ₹2.06 Cr | -67.14 | |
Mar2022 | ₹6.28 Cr | -12.25 | |
Mar2021 | ₹7.16 Cr | 25.07 | |
Mar2020 | ₹5.72 Cr | - |
Compare Total Current Liabilities of peers of GENPHARMASEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENPHARMASEC | ₹113.0 Cr | -10.1% | -31.8% | -49.4% | Stock Analytics | |
SUDARSHAN CHEMICAL INDUSTRIES | ₹6,956.1 Cr | -7.9% | -20.9% | 55.2% | Stock Analytics | |
KIRI INDUSTRIES | ₹2,997.6 Cr | -7.9% | -5.2% | 42.6% | Stock Analytics | |
VIDHI SPECIALTY FOOD INGREDIENTS | ₹2,222.1 Cr | -3.5% | -17.5% | 6.5% | Stock Analytics | |
BODAL CHEMICALS | ₹727.8 Cr | -11.6% | -10.9% | -26.7% | Stock Analytics | |
BHAGERIA INDUSTRIES | ₹714.9 Cr | -8.8% | -8% | 1.5% | Stock Analytics |
GENPHARMASEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENPHARMASEC | -10.1% |
-31.8% |
-49.4% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses